Yahoo Web Search

Search results

    • Merck to buy eye drug developer for $1.3B

      Merck to buy eye drug developer for $1.3B

      BioPharma Dive via Yahoo Finance· 5 hours ago

      An acquisition of EyeBio will hand Merck a treatment for diabetic macular edema and age-related macular degeneration that’s ready for pivotal testing.